Gevo, Inc. Files 8-K for Material Definitive Agreement
Ticker: GEVO · Form: 8-K · Filed: Sep 18, 2025 · CIK: 1392380
Sentiment: neutral
Topics: material-definitive-agreement, filing, corporate-action
Related Tickers: GEVO
TL;DR
Gevo signed a big deal, filing an 8-K today.
AI Summary
On September 18, 2025, Gevo, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits, but specific details of the agreement, involved parties, or financial figures were not disclosed in the provided text.
Why It Matters
This filing indicates Gevo has entered into a significant agreement, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could carry significant implications for the company, but the lack of specific details makes the risk level uncertain.
Key Players & Entities
- Gevo, Inc. (company) — Registrant
- September 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-35073 (identifier) — Commission File Number
- 87-0747704 (identifier) — IRS Employer Identification No.
- 345 Inverness Drive South, Building C, Suite 310 (address) — Principal executive offices
- Englewood, CO 80112 (address) — Principal executive offices
- 303-858-8358 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement filed by Gevo, Inc.?
The provided text does not specify the nature of the material definitive agreement.
Who are the parties involved in the material definitive agreement?
The filing does not disclose the names of the parties involved in the agreement.
What is the effective date of the material definitive agreement?
The filing indicates the report date is September 18, 2025, and this is the earliest event reported, suggesting the agreement is effective around this date, but no specific effective date is stated.
Are there any financial terms associated with the material definitive agreement mentioned in the filing?
No specific financial terms or amounts related to the agreement are provided in the text.
What is the purpose of filing financial statements and exhibits with this 8-K?
The filing states that financial statements and exhibits are included, typically to provide supporting documentation for the reported events, but their specific content related to the agreement is not detailed.
Filing Stats: 711 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2025-09-18 16:05:43
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share GEVO Nasdaq Capital Mark
- $26 million — which Gevo agreed to sell approximately $26 million worth of carbon dioxide removal credits
Filing Documents
- tm2526350d1_8k.htm (8-K) — 27KB
- tm2526350d1_ex10-1.htm (EX-10.1) — 198KB
- 0001104659-25-091236.txt ( ) — 418KB
- gevo-20250918.xsd (EX-101.SCH) — 3KB
- gevo-20250918_lab.xml (EX-101.LAB) — 33KB
- gevo-20250918_pre.xml (EX-101.PRE) — 22KB
- tm2526350d1_8k_htm.xml (XML) — 4KB
01. Entry into a Material
Item 1.01. Entry into a Material Definitive Agreement. On September 18, 2025, Net-Zero Richardton, LLC ("Gevo"), a subsidiary of Gevo, Inc., entered into a Carbon Dioxide Removal Sales Agreement (the "Agreement") with Biorecro North America, LLC ("Biorecro" and, together with Gevo, the "Parties" and, each, a "Party"), pursuant to which Gevo agreed to sell approximately $26 million worth of carbon dioxide removal credits ("CDR credits") associated with its carbon capture and sequestration facilities in Richardton, North Dakota to Biorecro with a portion of the sales to occur each quarter over the term of the Agreement. Biorecro has the option to purchase additional CDR credits each quarter upon notice to Gevo and Gevo's agreement to sell such additional CDR credits. The Agreement became effective on September 18, 2025, and will continue in full force and effect until December 31, 2030. Biorecro may extend the term for up to an additional ten years subject to Biorecro's satisfaction of certain conditions for the extension. The Parties may terminate the Agreement in the event that a Party fails the pay the other Party any undisputed amount pursuant to the Agreement or if certain customary events of default occur and are not cured within a certain time period. Upon the termination of the Agreement due to an event of default, the non-defaulting Party will be entitled to remedies at law or equity, subject to customary limitations on liability contained in the Agreement. The Agreement contains certain customary representations, warranties, covenants and confidentiality provisions. The foregoing description of the Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Agreement, a copy of which is attached hereto as Exhibits 10.1 to this Current Report on Form 8-K and are incorporated herein by reference.
01. Financial Statements
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 10.1 Carbon Dioxide Removal Sales Agreement, dated September 18, 2025, by and between Net-Zero Richardton, LLC and Biorecro North America, LLC. 104 Cover Page Interactive Data File (Formatted as Inline XBRL) Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GEVO, INC. Dated: September 18, 2025 By: /s/ E. Cabell Massey E. Cabell Massey Vice President, Legal and Corporate Secretary